CTRI/2020/03/023961.
Study name | A randomized controlled trial of levetiracetam vs phenobarbitone for treatment of neonatal seizures |
Methods | RCT |
Participants | Neonates (35‐42 weeks) with seizures |
Interventions | PB 20‐30 mg/kg vs LEV 20‐30 mg |
Outcomes | Seizure control within 1 hour, recurrence of seizures, adverse events (respiratory depression, heart rate fluctuation, duration of hospitalisation) |
Starting date | 2020 |
Contact information | manikant7@yahoo.com |
Notes | Estimated sample size 90, EEG not specified |